EVP/General Counsel Zachary Jennifer sells 121,573 shares for $14,485,690.41, reducing stake 63.8%
Zachary Jennifer, EVP and General Counsel at Merck, executed 3 separate sales on 2026-02-09 totaling 121,573 shares (121.6K shares) for $14,485,690.41 at $119.15 per share, cutting his holdings from 190,488 shares (190.5K shares) to 68,915 shares (68.9K shares)—a 63.8% reduction. The sales occurred near the 52-week high (current price $117.65 is -3.5% from the 52-week high of $121.93), and the company's fundamentals remain solid with $17,276,000,000.00 in quarterly revenue, $5,785,000,000.00 net income, and a P/E of 15.34. Across his cross-ticker track record, Jennifer's 2 prior sells had an average 90d return of -4.5% with a 50.00% well-timed rate; at Merck specifically, his prior 2 sells showed mixed timing (one neutral at 90d, one poorly timed at +1.0% and -10.1%). The combination of a substantial reduction in absolute holdings, execution near 52-week highs, and his inconsistent prior timing at this ticker presents a signal worth monitoring for broader context around executive confidence.